Gene · 1650
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural and functional analysis of aquaporin-2 mutants involved in nephrogenic diabetes insipidus. | Sci Rep | 2023 | 37674034 | PubTator, text mining | PubMed |
| Golgi α-mannosidases regulate cell surface N-glycan type and ectodomain shedding of the transmembrane protease corin. | J Biol Chem | 2023 | 37660903 | PubTator, text mining | PubMed |
| FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer. | J Exp Clin Cancer Res | 2023 | 37658376 | PubTator, text mining | PubMed |
| Investigation of the Catalytic Mechanism of a Soluble N-glycosyltransferase Allows Synthesis of N-glycans at Noncanonical Sequons. | JACS Au | 2023 | 37654596 | PubTator, text mining | PubMed |
| New insight into protein glycosylation in the development of Alzheimer's disease. | Cell Death Discov | 2023 | 37626031 | PubTator, text mining | PubMed |
| An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1. | Front Plant Sci | 2023 | 37615026 | PubTator, text mining | PubMed |
| An immune-related multi-omics analysis of dolichyl-diphosphooligosaccharide protein glycosyltransferase in glioma: Prognostic value exploration and competitive endogenous RNA network identification. | IET Syst Biol | 2023 | 37606290 | PubTator, text mining | PubMed |
| Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer. | J Inflamm Res | 2023 | 37593196 | PubTator, text mining | PubMed |
| The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy. | Front Immunol | 2023 | 37575234 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review. | Heliyon | 2023 | 37496898 | PubTator, text mining | PubMed |
| Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. | Int J Mol Sci | 2023 | 37445737 | PubTator, text mining | PubMed |
| Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging. | Cells | 2023 | 37443718 | PubTator, text mining | PubMed |
| Therapy-induced APOBEC3A drives evolution of persistent cancer cells. | Nature | 2023 | 37407818 | PubTator, text mining | PubMed |
| Structural and mechanistic studies of the N-glycosylation machinery: from lipid-linked oligosaccharide biosynthesis to glycan transfer. | Glycobiology | 2023 | 37399117 | PubTator, text mining | PubMed |
| A Role for Advanced Glycation End Products in Molecular Ageing. | Int J Mol Sci | 2023 | 37373042 | PubTator, text mining | PubMed |
| Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism. | Cells | 2023 | 37371132 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor. | Acta Pharm Sin B | 2023 | 37360012 | PubTator, text mining | PubMed |
| Inference and reconstruction of the heimdallarchaeial ancestry of eukaryotes. | Nature | 2023 | 37316666 | PubTator, text mining | PubMed |
| Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution. | Front Endocrinol (Lausanne) | 2023 | 37305044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1650/papers?page=6